- Home
- LEGN vs OBDC Comparison
LEGN vs OBDC Comparison
Compare LEGN & OBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LEGN | OBDC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.6B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LEGN | OBDC |
|---|---|---|
| Price | $20.26 | $11.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $61.33 | $14.00 |
| AVG Volume (30 Days) | 2.5M | ★ 4.2M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 13.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | N/A |
| Revenue This Year | $42.68 | N/A |
| Revenue Next Year | $30.52 | N/A |
| P/E Ratio | ★ N/A | $146.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.24 | $10.52 |
| 52 Week High | $37.50 | $14.44 |
Technical Indicators
Market Signals| Indicator | LEGN | OBDC |
|---|---|---|
| Relative Strength Index (RSI) | 39.82 | 64.95 |
| Support Level | $20.21 | $10.69 |
| Resistance Level | $20.39 | $11.91 |
| Average True Range (ATR) | 0.84 | 0.27 |
| MACD | 0.41 | 0.10 |
| Stochastic Oscillator | 47.51 | 87.45 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About OBDC Blue Owl Capital Corporation
Blue Owl Capital Corp is a specialty finance company and business development company (BDC) focused on providing direct lending solutions to U.S. middle-market companies. The company seeks to generate current income and, to a lesser extent, capital appreciation by targeting investment opportunities with favorable risk-adjusted returns, including senior secured, subordinated, or mezzanine loans and equity-related instruments. Its investment strategies are intended to generate favorable returns across credit cycles with an emphasis on preserving capital.